Medulloblastoma spreads by leptomeningeal dissemination rather than by infiltration that characterizes other CNS tumors, eg, gliomas. This study represents an initial attempt to identify both the molecules that mediate medulloblastoma adhesion to leptomeninges and the pathways that are key to survival and proliferation of tumor following adhesion. As a first step in molecule identification, we produced adhesion of D283 medulloblastoma cells to the extracellular matrix (ECM) of H4 glioma cells in vitro. Within this context, D283 cells preferentially expressed the a9 and b1 integrin subunits; antibody and disintegrin blockade of a9 and b1 binding eliminated the adhesion. The H4 ECM was enriched in tenascin, a binding partner for the a9b1 integrin heterodimer. Purified tenascin-C supported D283 cell adhesion. The adhesion was blocked by antibodies to a9 and b1 integrin. In vivo data were similar; immunohistochemistry of primary human medulloblastomas with leptomeningeal extension demonstrated increased expression of a9 and b1 integrins as well as tenascin at the interface of brain and leptomeningeal tumor. These data suggest that tumor-cell expressions of a9 and b1 integrins in combination with extracellular tenascin are necessary for medulloblastoma adhesion to the leptomeninges. As a first step in the identification of pathways that mediate survival and proliferation of tumor following adhesion, we demonstrated that adhesion to H4 ECM was associated with survival and proliferation of D283 cells as well as activation of the MAPK pathway in a growth factor deficient environment. Antibody blockade of a9 and b1 integrin binding that eliminated adhesion also eliminated the in vitro survival benefit. These data suggest that adhesion of medulloblastoma to the meninges is necessary for the survival and proliferation of these tumor cells at the secondary site.
In leptomeningeal dissemination, tumor cells migrate from the primary site to the surface of the brain and spinal cord, adhere to these secondary sites, and establish new colonies. 4 Risk factors for leptomeningeal dissemination have been identified [5] [6] [7] and some recent studies suggest that expression of ERBB2, PDGFR-a, and PDGFR-b stimulates the migration of medulloblastoma cells. 6, 8 However, the mechanisms of adhesion and survival following spread are not understood.
Adhesion of medulloblastoma cells to the leptomeninges has received little attention since the 1990s. Early investigations suggested a promising in vitro model for leptomeningeal dissemination: in a series of articles from 1986 to 1988, Rutka et al [9] [10] [11] [12] [13] [14] produced medulloblastoma adhesion to the leptomeningeal extracellular matrix (ECM) in a cell culture model. These investigators identified key proteins in ECM, including fibronectin, procollagen III, laminin, and collagen IV; however, the relatively small number of adhesion factors recognized at that time precluded identification of the specific molecules that mediate attachment. In 1991, Wikstrand, Friedman, and Bigner explored adhesion of six different medulloblastoma cell lines to three proteins (fibronectin, laminin, collagen IV) and Matrigel, but could not replicate Rutka et al's success in producing adhesion to these proteins. 15 We found no published studies of medulloblastoma adhesion to the leptomeninges after 1991.
Understanding of cell adhesion in the nervous system has progressed significantly during the past 15 years. 16, 17 Of particular relevance to leptomeningeal dissemination is the identification of the three largest families of neural adhesion molecules, N-cadherins, N-CAMs, and integrins. Medulloblastomas express all three of these molecules [18] [19] [20] [21] [22] [23] but available evidence suggests that not all three mediate leptomeningeal dissemination. N-cadherins and N-CAMs bind homophilically to form N-cadherin-N-cadherin and N-CAM-N-CAM bonds; these pairings may mediate cell-cell adhesion within the primary tumor. 15 However, the minimal expression of N-cadherins and N-CAMs in the meninges [24] [25] [26] suggests that these molecules are unlikely mediators of medulloblastoma adhesion to the meningeal surface. In contrast, integrins bind to a range of ECM proteins, many of which are expressed in the leptomeninges. These include collagens I, 11, 27 III, 9, 11, 14 IV, 11, 25, 27 and VI; 28 procollagen III; 11 fibronectin; 11, 26 tenascin; 29 laminin; 11, 25, 27, 30 vitronectin; 31 and thrombospondin. 32 Integrins are also critical to the adhesion of other cancers that disseminate by surface spread rather than by infiltration, eg, ovarian cancer and mesothelioma. [33] [34] [35] [36] We hypothesized a similar role for integrins and ECM proteins in leptomeningeal dissemination, ie, specific integrin-ECM protein pairings are necessary for the adhesion of medulloblastoma cells to the meninges.
The Akt and MAPK pathways are mediators of the survival and proliferation of many disseminated cancers but their role in disseminated medulloblastoma has not been investigated. 37 When growth factor is available, the two pathways are activated independently; Akt is activated by integrins following adhesion to ECM and MAPK is activated by soluble growth factors (Figure 1 ). However, in a growth factor poor environment, both are activated by integrins following adhesion. 37 Adhesion triggers integrin clustering and recruitment of adaptor molecules to focal adhesion complexes that are composed of a variety of protein kinases and adaptor molecules, including integrin-linked kinase (ILK), phosphatidylinositolphosphate-3, 4, 5 triphosphate, parvins, and paxillin; ILK activates Akt. In a growth factor deficient environment, growth factor cannot bind to RTK and, consequently, RTK to MAPK signaling does not occur. Instead, ILK engages a number of adaptor molecules, most notably PINCH-1 and Nck2. Nck2 subsequently activates MAPK through interaction with the cytoplasmic domain of RTK. 39, 38 The leptomeninges are a growth factor poor environment; 40, 41 as such, MAPK is unlikely to be activated by RTK signaling. We hypothesized that integrin adhesion to ECM in the process of leptomeningeal dissemination leads to activation of Akt and MAPK.
This study attempted to extend Rutka et al's previously successful approach by combining their in vitro model 13 with recently developed immunoassays for integrin subunits and their ECM-binding partners. We produced adhesion of medulloblastoma cells to H4 ECM in vitro and used these novel immunoassays to identify a9b1 integrin on the cell surface and tenascin in the ECM as the molecules that mediate this process. We then confirmed these findings in vivo through immunohistochemistry of medulloblastoma surgical specimens. Finally, we demonstrated that a9b1 integrin-mediated adhesion is necessary for survival and proliferation of medulloblastoma cells in a growth factor poor environment and is associated with activation of the MAPK pathway.
MATERIALS AND METHODS Reagents
Bovine serum albumin (BSA), EDTA, Triton-X100, fibronectin, laminin, and human insulin-like growth factor 1 (IGF-1) were purchased from Sigma (St Louis, MO, USA). Human tenascin-C was purchased from Millipore/Chemicon (Billerica, MA, USA). DMEM was purchased from ATCC (Manassas, VA, USA). All other cell culture products were purchased from Invitrogen/ Gibco (Carlsbad, CA, USA). Monomeric and heterodimeric disintegrins were purified from lyophilized viper venoms as previously described. 44, 45 The D283 medulloblastoma cell line was selected as the source of medulloblastoma cells because these cells originated in a tumor that had undergone leptomeningeal dissemination. All cell lines were maintained in ATCC DMEM with 10% fetal bovine serum. Cell counts were performed manually with a Brightline hematocytometer (Fisher Scientific, Pittsburgh, PA, USA). Cell viability was determined by trypan blue exclusion. Of note, in our hands the D283 cell line grows largely as nonadherent spheroids with a minority of the cells loosely attached to the plastic tissue culture flasks. To avoid introducing bias into the results by selecting one or the other of these populations the cells were harvested from the flasks with gentle scraping to insure that the adherent and nonadherent cells were equally represented. This was followed by trituration to dissociate the spheroids before counting. Experiments that required serum-free medium were performed in ATCC DMEM without additives. Petri dishes and 96-well plates were coated with fibronectin and laminin at 5 mg/ml. H4 ECM-coated surfaces were created with confluent cultures of H4 glioma cells grown on plastic surfaces. The cells surfaces were stripped with 0.1% Triton-X100 (30 min at RT) followed by 25 mM NH 4 OH (1-2 min) and three rinses with DH 2 0. 46 This preparation was used directly as H4 ECM for the experiments described. To achieve anchorage independence, sterile Petri dishes without tissue culture treated surfaces were coated with polyhema (Sigma; 12 mg/ml in 95% ETOH, 0.8 mg/cm 2 ).
Cell Adhesion Assays to Antibodies, Disintegrins, and Purified ECM Proteins Antibodies and disintegrins were immobilized on 96-well microtiter plates (Falcon, Pittsburgh, PA, USA) by overnight incubation in phosphate-buffered saline (PBS) at 41C. Antibodies were coated at 10 mg/ml, and disintegrins were coated at 20 mg/ml. Wells were blocked with 1% BSA at 371C for 1 h. Cells were labeled by incubation with 12.5-25 mM 5-chloromethylfluorescein diacetate (CMFDA) in Hank's balanced salt solution (HBSS) containing 1% BSA for 15 min. Unbound label was removed by washing in the same buffer.
(For experiments requiring calcium-free medium, calciumfree HBSS supplemented with 5 mM EDTA was used.) Labeled cells were counted by hemocytometer and diluted to a concentration of 10 6 cells/ml. A portion of 100 ml (10 5 cells) was then added to each well and plates were incubated at 371C for 30 min. Unbound cells were removed by washing, and bound cells were lysed by the addition of 0.5% Triton X-100. A standard curve was prepared using known concentrations of labeled cells. Plates were read using a Cytofluor 2350 fluorescence plate reader (Millipore) with a 485-nm excitation filter and a 530-nm emission filter. For inhibition studies, an identical protocol was followed, except that the cells were incubated with antibodies (10 mg/ml) for 1 h at 371C before the addition of CMFDA. The percentage inhibition of binding was calculated by comparison with the fluorescence values obtained from control samples without added antibody. For the experiments with adhesion to purified ECM proteins, human tenascin-C and collagen IV were coated at 1 ug/cm 2 for 1 h at 371C. Assays were conducted with the same technique as above except that wells were not blocked with BSA and plates were incubated at 371C for 1.5-2 h to achieve adhesion.
Elisa Assay for ECM Protein Content of H4 Matrix 96-Well plates coated with H4 ECM were blocked with 1% BSA in Tris-buffered saline (TBS)/Tween 20 (TBST) buffer at 371C for 1 h. Either rabbit polyclonal (1 mg/ml) or mouse monoclonal (5 mg/ml) antibodies were added in TBST, and the plate was incubated for 2 h at 371C. Wells were washed four times with TBST. Alkaline phosphataseconjugated goat anti-rabbit or anti-mouse (Sigma) was diluted 1:3000 in TBST plus 1% BSA and incubated for 1 h with the plate. After washing four times with TBST, Sigma 104 alkaline phosphatase substrate at 1 mg/ml in TBS, pH 9.0, was added to each well. Color development was monitored at 405 nm.
Immunocytochemistry D283 cells were passaged onto H4 ECM-coated microscope slide culture chambers (Labtech; Nalge NUNC Intl, Rochester, NY, USA) and incubated for 24-48 h at 371C under standard cell culture conditions. The resulting cultures were fixed in cold (41C) acetone for 1-3 min and then washed three times in PBS. Slides were blocked in 10% normal horse serum in PBS 0.1% BSA for 30 min. Incubation in primary antibodies (diluted in 0.1% PBS-BSA) was at 371C for 1 h. Slides were washed three times in PBS and incubated in secondary fluorescent antibody (1:500; Vector Labs, Burlingame, CA, USA) in 0.1% PBS-BSA for 1 h. in dark. The resulting slides were washed three times in PBS and mounted with water soluble medium (Vectashield; Vector) before fluorescence microscopy.
Immunohistochemistry
Antibodies to the a9 and b1 integrin subunits and the ECM proteins tenascin, fibronectin, laminin, and collagen IV were used to stain normal adult human cerebellum and seven surgical specimens of cerebellar medulloblastoma with leptomeningeal extension obtained from the UHN Pathology Archive. The medulloblastoma specimens selected contained both the primary tumor and the interface between cerebellum and leptomeningeal tumor. The histologic subtypes of these tumors were classic 4 and nodular/desmoplastic. Paraffin-embedded sections (4-6 mm thick) were dewaxed in xylene and rehydrated in ascending alcohols. Following antigen retrieval with Na citrate (10 mM, pH 6.0 heating to 1201C for 2 min in decloaking chamber (Biocare, Concord, CA, USA)) or pepsin (1% in 0.01 N HCl, pH 2.0 for 15 min at 371C), sections were incubated with primary antibody at room temperature. In preparation for anti-a9 integrin staining, tissue was pretreated with pepsin; primary antibody was applied at 1/4000 dilution for 1 h. For anti-b1 integrin staining, tissue was pretreated with pepsin; primary antibody was applied at 1/100 for 1 h. For antitenascin staining, tissue was pretreated with pepsin; primary antibody was applied at 1/4000 dilution overnight. For antifibronectin staining, tissue was pretreated with pepsin; primary antibody was applied at 1/1000 dilution for 1 h. For antilaminin staining, tissue was with pepsin; primary antibody was applied at 1/100 dilution for 1 h. For anti-collagen IV staining, tissue was pretreated with citrate; primary antibody was applied at 1/100 dilution for 1 h. Primary antibodies were subsequently amplified with secondary antibody and then with avidin-biotin complex coupled to horseradish peroxidase. Chromagen was developed with diaminobenzidine. Following light counterstaining with hematoxylin, sections were dehydrated and coverslipped with permount.
Western Blots
Cells were lysed in 50 mmol/l HEPES (pH 7.5), 150 mmol/l NaCl, 1.5 mmol/l MgCl 2 , 1 mmol/l EGTA, 10% glycerol, 1% Triton X-100, 1 mmol/l phenylmethylsulfonyl fluoride, 0.2 mmol/l sodium orthovanadate. Aliquots of 50 mg of protein extracts were separated in a 4% to 15% gradient SDS-PAGE (Bio-Rad, Hercules, CA, USA) and transferred onto nitrocellulose membranes. The resulting blots were blocked in 5% nonfat milk and probed with anti-Erk 1/2 and anti-phospho-Erk as well as 1/2 anti-Akt and anti-phosphoAkt (Ser473). In addition, blots were probed for GRB2 as a loading control. Western blots were developed with the ECL system (Perkin Elmer) and archived onto KODAK X-OMAT film. Films were scanned with Alphaimager HP and analyzed with GelFox (Alphainnotech, San Leandro, CA, USA).
Charts and Statistical Measures
The between-group differences from cell adhesion assays, ELISA assays, and western blots were initially tested for significance via single-factor ANOVA. One-tailed t-tests were subsequently performed to assess differences between groups; unequal variance across groups was assumed. Po0.05 was considered statistically significant for all comparisons. All analyses and graphs were performed with Microsoft Excel. Asterisks above bars indicate significant differences. Error bars on graphs represent the standard error of the mean. Each datapoint represents the average of the data obtained from three to five experiments. In each experiment, there were either duplicate or triplicate wells/conditions. As such, each datapoint represents the average of 6-15 independent measures. Figure 2 provides phase-contrast images of D283 cells grown for 24 h on tissue culture plastic, laminin, fibronectin, and H4 matrix. In comparison to the loose adherence normally shown by D283 cells on tissue culture plastic (a) no qualitative increase in surface attachment was observed with laminin (b); and a modest increase in attachment was observed in the context of fibronectin (c). In contrast, D283 cells demonstrated significant adhesion to the H4 matrix (d); the spreading expected to follow surface attachment in epithelial cells was also observed.
RESULTS

Medulloblastoma Cells Adhere to H4 Glioma Matrix
Adhesion to H4 Glioma Matrix is Dependent on Extracellular Ca þ þ Concentration When D283 cells were incubated in H4 matrix-coated wells in the presence of Ca þ þ , adhesion of 15 000 cells per well was observed. In contrast, when these cells were incubated in the absence of Ca þ þ , adhesion of only 1000 cells per well was observed. This 15-fold decrement in adhesion was significant (Po0.02; Figure 3 ). This suggests that adhesion is mediated by cationic dependent molecular pairings such as those between integrins and ECM proteins; cationic independent pairings would predominate if N-CAMs accounted for the adhesion of D283 cells to H4 matrix.
16,17
Medulloblastoma Cells Express a9 and b1 Integrin Subunits The level of integrin expression by D283 cells was determined by semiquantitative assays of D283 cell adhesion to antiintegrin antibodies immobilized on 96-well plates (Figure 4 ). The 15 anti-integrin antibodies included 9 to a-subunits (1, 2, 3, 4, 5, 6, 9, L, M), 3 to b-subunits, 1,2,4 and 2 to heterodimers avb3 and avb5. ANOVA demonstrated significant differences among a-subunit group measures (Po1.1 Â 10 À11 ). Subsequent t-tests demonstrated that expression of the a9-subunit was significantly greater than expression of the eight other a-subunits and the av-heterodimer (Po0.03 for all t-tests performed). Similarly, ANOVA demonstrated significant differences among b-subunit group measures (Po2.0 Â 10
À11
) and subsequent t-tests demonstrated that expression of the b1-subunit was significantly greater than expression of the two other b-subunits and the avb3 and avb5 heterodimers (Po4.6 Â 10 À5 for all t-tests performed).
Antibodies and Disintegrins against a9 and b1 Integrins Inhibit Adhesion of Medulloblastoma Cells to H4 Matrix
Eight of the antibodies used in the adhesion assays above (a1, a2, a3, a9, b1, b2, b4, avb3) were added to aliquots of D283 cells at a concentration (10 mg/ml) sufficient to complex with the majority of integrin subunits expressed on the cell surfaces. These cells were then placed in wells coated with H4 ECM and their adhesion to that surface assayed (Figure 5a ). Antibody to the a9-subunit inhibited 99% of adhesion and antibody to the b1-subunit inhibited 100% of adhesion to the H4 matrix. Again, ANOVA demonstrated significant differences among the eight subunit groups (Po4.8 Â 10 À14 ). t-Tests demonstrated significantly greater inhibition for a9 and b1 than for all the other subunits (a1, a2, a3, b2, b4, avb3; Po0.005 for all t-tests performed).
In a parallel experiment, disintegrin peptides, snake venom proteins with selective abilities to complex with integrins, were employed with the same assay design (Figure 5b) . VLO5, which binds to the a9b1 integrin heterodimer, 43 inhibited 95% of adhesion. Echistatin, which does not block the a9 integrin subunit but is a potent antagonist of aIIbb3, avb3, and a5b1, 42, 47 inhibited only 25% of adhesion. The extent of inhibition by VLO5 was significantly different from the extent of inhibition by Echistatin (Po0.04).
Tenascin is the Predominant H4 ECM Protein
The a9b1 heterodimer is known to bind preferentially to tenascin-C or VCAM-1 and the b1-subunit interacts with a variety of ECM proteins including fibronectin, laminin, vitronectin thrombospondin-1, collagen, and Von Willebrand Factor. 42, 47 Antibodies to these proteins were used in an ELISA format to assay H4 matrix-coated wells ( Figure 6 ). The signal for antitenascin was more than twice as intense as that of the next largest signal (collagen IV). Single-factor ANOVA demonstrated significant differences among signal intensities (Po3.4 Â 10
À10
), and subsequent t-tests demonstrated significant difference between the tenascin signal and the intensity of all other signals (Po0.006 for all t-tests performed).
Medulloblastoma Cells' Adhesion to Purified Tenascin is Dependent on a9 And b1 Integrins As tenascin and collagen IV are the two most abundant proteins in the H4 matrix, we compared D283 cell adhesion to isolated, purified tenascin-C, and collagen IV. 8% of cells adhered to tenascin-C, 4% to collagen IV, and 2% to the control-untreated tissue culture plastic. (See Figure 7a. ) Singlefactor ANOVA demonstrated significant differences among these percentages (Po3 Â 10
À4
). Notably, the percent of D283 cells that adhered to tenascin-C was greater than the percent that adhered to both collagen IV and control (Po0.049).
In parallel assays, D283 cells were incubated in anti-a9 or anti-b1 integrin and then were placed in wells coated with tenascin-C or collagen IV. Antibody to a9 inhibited 65% of adhesion to tenascin-C but only 25% of adhesion to collagen IV. Antibody to b1 inhibited 60% of adhesion to tenascin-C but only 32% of adhesion to collagen IV. t-Tests demonstrated significantly greater a9 and b1 inhibition of adhesion to tenascin-C than to collagen IV (Po2 Â 10 À4 and 0.03 respectively; asterisks in Figure 7b ). (Figure 8a and b) . Cells stained in parallel with either antibody to b2 integrin or FITC-labeled bitisatin (a disintegrin that does not bind either the a9 or b1 integrin) 42 did not label (data not shown).
Immunohistochemistry of Surgical Specimens Demonstrates Increased a9 and b1 Integrin and Tenascin Reactivity in Leptomeningeal Medulloblastoma
In normal cerebellum (Figure 9a) antibodies to a9 integrin, b1 integrin, tenascin, laminin, and collagen IV demonstrated minimal staining. The endothelium was sparsely labeled by a9, b1, and laminin; the vascular media also stained weakly with tenascin and collagen IV (black arrows). Focal leptomeningeal staining for a9 integrin, b1 integrin, tenascin, and laminin was observed (red arrows). There was no staining for fibronectin; this is consistent with data from previous studies of paraffin-embedded aldehyde-fixed normal CNS tissues. [48] [49] [50] [51] [52] However, our positive controls for fibronectin including human lung, colon, and kidney did demonstrate staining of the basement membrane side of the vasculature (data not shown).
Primary medulloblastomas (Figure 9b ) also demonstrated low levels of reactivity for a9 and b1 integrin. In the seven tumors, antibody to the a9 integrin labeled the cell surface of two (one classic, one nodular) and anti-b1 integrin labeled six (three classic, three nodular). Discrete tenascin reactivity was observed between the cells of one nodular tumor. Although the source of the tenascin staining is not known, it may represent reactive astrocytic processes that are often present in medulloblastomas 53 and are known to express tenascin. 54 Vessels within six of these seven tumors demonstrated reactivity for fibronectin (red arrows). Antilaminin demonstrated focal positivity in two tumors (one classic, one nodular) as well positive, more intense vascular staining than the control cerebellum (red arrow). There was no collagen IV staining of tumors. As with fibronectin and laminin, occasional vascular staining was observed (red arrow). The increased vascular labeling for fibronectin, laminin, and collagen IV may reflect the diminution of blood brain barrier integrity within the tumor that allows subendothelial deposition of ECM proteins. 51, 52 In the nodular medulloblastomas, there was no preferential immunoreactivity of the nodular or internodular regions with any of the antibodies.
Most leptomeningeal extensions of tumor (Figure 9c ) demonstrated increased reactivity for a9, b1, and tenascin. Medulloblastoma: adhesion and survival P Fiorilli et al
The pattern of expression was similar across tumors, ie, a9 and b1 expression was greatest at the periphery of the leptomeningeal tumor implants (black arrows) but tenascin was concentrated in the deeper parts of the leptomeningeal tumor (red arrows). This pattern characterized the two tumors originally positive for a9, five of the six originally positive for b1, and all six of those originally negative for tenascin. There was no increased reactivity for fibronectin, laminin, or collagen IV in any extension although occasional laminin positive vessels were seen (black arrows). Matrix Adhesion is Necessary for D283 Cell Survival in Serum-Free Conditions To test the effect of surface adhesion on the survival of leptomeningeal tumor, 10 5 D283 medulloblastoma cells were plated in wells with serum-free medium (Figure 10 ). The viability of cells plated on H4 matrix was only 55% at 24 h and 40% at 48 h but was restored to 80% of the input value by 72 h due to proliferation. In the absence of H4 matrix, 80% of cells were nonviable after 72 h. Addition of blocking antibody to either a9 or b1 integrin to cells cultured in H4 matrix-coated wells produced survival curves similar to those observed for the nonadherent cells. Microscopic observation of the wells to which antibody was added revealed that cells failed to adhere to substrate; this suggests that surface adhesion and cell survival are closely linked in serum-free cultures.
The decreased survival on days 1 and 2 among D283 cells on ECM is consistent with the absence of normal growth Medulloblastoma: adhesion and survival P Fiorilli et al conditions for these cells, ie, the absence of nonadherent spheroids. Adhesion to matrix eliminates the spheroid formation and, as a result, is likely to decrease cell-cell signaling; as such, additional time may be required for cells to develop alternate signaling pathways that promote proliferation.
Effects of Matrix Adhesion on Activation of Akt and MAPK D283 medulloblastoma cells cultured in serum-free DMEM (ATCC) for 18-24 h in surface nonadherent conditions (polyhema-coated plates) were transferred to H4-coated plates. Parallel cultures in dishes coated with polyhema to block adhesion but treated with IGF1 (50 ng/ml for 0.5 h) served as positive controls; cells that were not transferred served as negative controls. Plates were harvested at 0.5, 1, 2, and 4 h. Proteins were extracted (50 mg per lane electrophoresed on 7.5% ¼ acrylamide gels) and blotted to nylon membranes. The membranes were sequentially probed with antibodies to phospho-Erk1/2 and total Erk1/2. Membranes were reprobed with antibodies to phospho-Akt (Ser 473) and Medulloblastoma: adhesion and survival P Fiorilli et al total Akt. Single-factor ANOVA demonstrated significant differences in levels of Erk1/2 phosphorylation across groups (Po0.05; Figure 11a ). Phospho-Erk1/2 demonstrated a threefold increase relative to the positive control at 0.5 h (Po0.02). Phospho-Erk1/2 demonstrated a significant increase relative to the negative control at 0.5 and 2 h following transfer to the adhesive matrix (Po0.007 and Po0.009, respectively) but was not significantly different at 4 h (Po0.04) Single-factor ANOVA demonstrated no significant differences in Akt phosphorylation across groups (Po0.81; Figure 11b ).
DISCUSSION
Both the in vitro and the in vivo data from this study suggest that adhesion of D283 medulloblastoma cells to the meninges is mediated by the interaction of cell surface a9 and b1 integrins with ECM tenascin. In vitro, a9 and b1 were the predominant integrin subunits expressed by the D283 cells and tenascin was the dominant protein expressed by the H4 matrix. Consistent with cationic dependent molecular pairings known to characterize integrins and ECM proteins, adhesion of the D283 cells to the H4 ECM was Ca þ þ concentration dependent. Blockade of the a9 and b1 integrins eliminated binding both to the H4 ECM and to tenascin-C. The percent of D283 cells that adhered to tenascin-C was significantly greater than the percent that adhered to collagen IV, the second most abundant protein in the H4 matrix. In vivo, immunohistochemistry of surgical specimens demonstrated increased expression of a9 and b1 integrins as well as tenascin at the junction of medulloblastoma and meninges. The data from this study also suggest that, in a growth factor deficient environment, a9 and b1 adhesion to ECM is critical to medulloblastoma cell survival and proliferation. D283 cells survived and proliferated in serum-free conditions following adhesion to ECM. Blockade of adhesion with antibodies to a9 and b1 integrins eliminated these survival and proliferation advantages. D283 cell adhesion, in turn, stimulated transient phosphorylation of MAPK; phosphorylation was not observed in the absence of adhesion. These MAPK activation data are similar to results of previous studies of integrin-mediated cell adhesion to substrate. 55, 56 In our study, 72 h elapsed before the proliferative advantage was observed. This interval may be explained by the known nuclear translocation of ERK1 and ERK2 that follows MAPK phosphorylation. This, in turn, phosphorylates transcription factors such as ELK1 and stimulates expression of cyclin D1, inducing cell cycling. 57, 58 Our finding of preferential MAPK activation following integrin-mediated adhesion is distinct from the marked activation of both the Akt and MAPK pathways that characterizes signaling following adhesion with the majority of integrin heterodimers. [37] [38] [39] Notably, the differential activation pattern we observed also describes the differential signaling of a4b1, the integrin with greatest structural similarity to a9b1; 43, 59, 60 this suggests the hypothesis that the similar signaling patterns of a9b1 and a4b1 are the result of their structural similarities. It also suggests that the MAPK pathway may play a greater role than the Akt pathway in the survival and proliferation of other cancer cells that express predominantly the a9b1 or a4b1 integrins.
The data from this study support the use of H4 glioma cells as a matrix source for the study of leptomeningeal dissemination. Our demonstration of adhesion, survival, and proliferation with H4 glioma cells as the substrate was similar to the results of the previous study that employed primary leptomeningeal cells as the substrate. 13 In addition, the similarities in results of the two studies parallel similarities in the ECM protein profiles of the two substrates, ie, expression of fibronectin, laminin, and collagen type IV. 9, 11, 14 The significant difference in the results of the two studies was our identification of tenascin as the dominant protein in the adhesion process; assays for tenascin were not widely available when the earlier investigation was conducted and, as such, the roles of tenascin in adhesion to the different substrates cannot be compared. The expression of tenascin in the in vivo meninges adjacent to disseminated medulloblastoma is consistent with the viability of H4 glioma cells as an appropriate matrix source for investigations of leptomeningeal dissemination. The additional protein profile similarities of H4 glioma cells and in vivo meninges, ie, expression of fibronectin, laminin, vitronectin, thrombospondin, and collagen type IV but no detectable VCAM or von Willebrand factor [25] [26] [27] [30] [31] [32] 61, 62 (also our immunohistochemical data) provide additional evidence for the appropriateness of H4 glioma cells as a substrate. Finally, the similarities in results between our study and the previous study 13 are consistent with the similarities in the anatomical roles of the H4 glioma and primary leptomeningeal cells. Both types of cells are observed in the meninges; the leptomeningeal cells comprise the arachnoidal trabeculae and the glial cells form the pia limitans. 44, 45 In summary, the results of this study provide preliminary evidence that coculture of D283 medulloblastoma cells with H4 glioma matrix results in adhesion of D283 cells to the ECM, and improved survival relative to nonadherent cells. Our results in vitro and in vivo also suggest that the expression of a9b1 by medulloblastoma cells and tenascin in the ECM is necessary for adhesion. Additional in vitro results suggest that this adhesion activates the MAPK pathway and is necessary for both cell survival and proliferation.
